Explaining the homogeneous diffusion of COVID-19 nonpharmaceutical interventions across heterogeneous countries.
Where this comes from
- Record sourced from PubMed, PMID 32788356.
- Also identified by DOI 10.1073/pnas.2010625117 and PMC identifier 7474611.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We analyze the adoption of nonpharmaceutical interventions in the Organisation for Economic Co-operation and Development (OECD) countries during the early phase of the coronavirus disease 2019 (COVID-19) pandemic. Given the complexity associated with pandemic decisions, governments are faced with the dilemma of how to act quickly when their core decision-making processes are based on deliberations balancing political considerations. Our findings show that, in times of severe crisis, governments follow the lead of others and base their decisions on what other countries do. Governments in countries with a stronger democratic structure are slower to react in the face of the pandemic but are more sensitive to the influence of other countries. We provide insights for research on international policy diffusion and research on the political consequences of the COVID-19 pandemic.
Medical subject headings
- Communicable Disease Control
- Coronavirus Infections
- Government
- Health Policy
- Pandemics
- Pneumonia, Viral